Pérez-García, José

Universitat Autònoma de Barcelona · Vall d'Hebron Hospital Universitari · Vall d'Hebron Institute of Oncology

1 paper on CoChatORCID 0000-0003-4238-2046

Most cited papers

Verified
A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
Bedard, P. L., Tabernero, J., Janku, F., Wainberg, Z. A., Paz-Ares, L., Vansteenkiste, J., Van Cutsem, E., Pérez-García, J., Stathis, A., Britten, C. D., et al. (2015) · Clinical Cancer Research
PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies
Cited by 324

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free